
Used to treat adult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient or intolerant response to one or more disease modifying antirheumatic drugs (DMARD). In terms of medication, filgotinib can be used as a monotherapy or in combination with methotrexate (MTX).
from FDA,2023.07
LuciusVersionofFilgotinib:DosageandAdministration,Indications,PrecautionsIndicationsRheumatoid Arthr···【more】
Recommended:1992025-10-12
Composition and Mechanism of Action of FilgotinibFilgotinib is a prescription drug whose core active ingredient is filgotinib, a member of the Janus kinase (JAK) inhibitor family. ···【more】
Article source:Lucius LaosRelease date:2026-07-13Recommended:59
Used for relapsed/refractory mantle cell lymphoma and other B-cell malignancies.【more】
Article source:Lucius LaosRelease date:2026-01-05Recommended:106
Adult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient or intolerant response to various disease modifying antirheumatic drugs (DMARD).【more】
Article source:Lucius LaosRelease date:2026-01-05Recommended:119
LuciusVersionofFilgotinib:DosageandAdministration,Indications,PrecautionsIndicationsRheumatoid ArthritisLuciFilgo is indicated for the treatment of adult patients with moderately t···【more】
Article source:Lucius LaosRelease date:2025-12-10Recommended:199

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643